---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-138802"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T13:11:28.813519+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics suspends ATM prospectus; Sales Agreement remains in effect

## Summary
- Delivered notice to Jefferies to terminate ATM prospectus dated Feb 6, 2025.
- No sales of common stock under Sales Agreement until new prospectus filed.
- Underlying Open Market Sale Agreement with Jefferies remains in full force.
- Company retains ability to resume ATM sales after filing new prospectus.

## SEC filing metadata
- accession: 0001193125-25-138802
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312525138802/0001193125-25-138802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312525138802/d779986d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-138802
- JSON: https://secwatch.observer/filing/0001193125-25-138802.json
- Plain text: https://secwatch.observer/filing/0001193125-25-138802.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.